News
Czech Republic Moves Toward Legal Medical Use of Psilocybin
The Czech Republic is on the verge of becoming one of the first European countries to legalize the medical use of psilocybin, an active compound found in psychedelic mushrooms....
DMT
Atai and Beckley Merge to Lead the Psychedelic Medicine Movement
Atai Life Sciences and Beckley Psytech, two major players in psychedelic medicine, have merged to form Atai Beckley. Their goal is to fast-track the...
News
Colorado’s Psychedelics Program Officially Begins
Colorado has taken a major step in the rollout of its voter-approved psychedelics program, becoming one of the first states in the U.S. to...
Iboga
Texas Prepares to Launch $50M Ibogaine Trial Program: A New Chapter in Psychedelic Medicine?
Texas is on the brink of launching the most ambitious state-backed psychedelic research initiative in U.S. history. A proposed $50 million public-private partnership aims...
Cannabis
Matthew Zorn’s Federal Role Signals Shift in U.S. Psychedelics and Cannabis Policy
The landscape of drug policy within the United States has been evolving rapidly, with a growing emphasis on marijuana rescheduling and the potential therapeutic...
Ayahuasca
Ayahuasca, Setbacks, and a New Vision: BPM Co-Founder Launches The 5th Element Festival
Phil Pulitano, one of the original minds behind BPM Festival, is turning a new page in 2025 with The 5th Element, a week-long dance...
News
How Psychedelics May Shift Brain Activity Toward the Right Hemisphere
A new theory from Ohio State University, called HEALS (Hemispheric Annealing and Lateralization Under Psychedelics), proposes that psychedelics change how the brain’s hemispheres interact....
Experience
A Psychedelic-Inspired Dining Experience Arrives in Washington, D.C.
Washington, D.C., known for its lively food scene, has welcomed a bold new concept that’s turning dinner into something much more imaginative. The restaurant...
Ketamine
Portugal Approves Esketamine for Severe Depression Treatment
Portugal has taken a significant step in mental health care by approving public funding for esketamine, a psychedelic drug used to treat severe depression....
News
Psilocybin-Assisted Therapy Shows Promise for Substance Use Disorders
A recent scientific review has examined the potential of psilocybin-assisted therapy (PAP) as a treatment for substance use disorders (SUDs), focusing on its impact...
MDMA
Psychedelics May Disrupt Immune-Driven Fear Responses, Offering New Hope for Mental Health Treatment
A groundbreaking study from Mass General Brigham has unveiled a previously unknown connection between the immune system and the brain's fear response. The research...

